510(k) K153301
K153301 is an FDA 510(k) premarket notification submitted by Roche Diagnostics for the device "Elecsys Digoxin Immunoassay, Elecsys PreciControl Cardiac II". The FDA issued a decision of Substantially Equivalent on Apr 8, 2016. The device falls under product code KXT (Enzyme Immunoassay, Digoxin), a Class II device regulated under 21 CFR 862.3320. Roche Diagnostics has 456 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Apr 8, 2016
- Date Received
- Nov 13, 2015
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Immunoassay, Digoxin
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type
- 510(k)
Need the full FDA record for Roche Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.